Bio-Techne Corp (TECH)

Financial leverage ratio

		Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020
Total assets	US$ in thousands	2,557,870	2,644,260	2,670,420	2,736,020	2,813,190	2,721,170	2,730,750	2,755,360	2,638,690	2,599,700	2,363,400	2,350,720	2,294,800	2,299,890	2,304,850	2,270,190	2,262,960	2,084,640	2,067,870	2,053,100
Total stockholders’ equity	US$ in thousands	1,918,810	2,018,020	2,078,490	2,138,650	2,068,850	2,014,380	1,963,560	1,997,750	1,966,520	1,889,690	1,827,110	1,751,150	1,701,010	1,713,320	1,702,530	1,646,960	1,571,230	1,547,940	1,530,850	1,439,280
Financial leverage ratio		1.33	1.31	1.28	1.28	1.36	1.35	1.39	1.38	1.34	1.38	1.29	1.34	1.35	1.34	1.35	1.38	1.44	1.35	1.35	1.43

June 30, 2025 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,557,870K ÷ $1,918,810K
= 1.33

The financial leverage ratio of Bio-Techne Corp over the observed period exhibits relatively stable variations, fluctuating within a narrow range. Starting at a high of 1.43 on September 30, 2020, the ratio generally declined to a low of 1.28 by the end of 2024, and then experienced slight increases thereafter, reaching approximately 1.36 by mid-2025. Throughout the period, the leverage ratio maintained values predominantly between 1.28 and 1.43, indicating a consistent level of financial leverage.

This pattern suggests that Bio-Techne has maintained a moderate and relatively stable degree of leverage, balancing debt and equity financing without significant shifts. The minimal fluctuations imply disciplined leverage management, avoiding considerable increases that could suggest financial risk, nor sharp declines that might limit growth opportunities. Overall, the company's leverage ratio indicates a prudent approach to debt utilization, supporting operational stability with manageable financial risk exposure over the analyzed timeframe.